Pigmented Villonodular Synovitis, Diffuse-type Giant Cell Tumor and Tenosynovial Giant Cell Tumor Clinical Trial Using nilotinib

- The folks at Dana-Farber Cancer Institute are studying the effects of nilotinib on Pigmented Villonodular Synovitis, Diffuse-type Giant Cell Tumor and Tenosynovial Giant Cell Tumor in individuals ages 18 years and older. This clinical trial is slated to start September 2010.

617-632-5204
Andrew J. Wagner, MD, PhD
Overall Study Contact Info
StatusName Contact Phone
RecruitingAndrew J. Wagner, MD, PhDanderw_wagner@dfci.harvard.edu617-632-5204

This study is officially titled, "A Multi-Center Single Agent Phase II Study of the Efficacy of Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor."

Locations

Sarcoma Oncology Center

Santa Monica, California - Not yet recruiting

Stanford University Medical Center

Stanford, California - Recruiting

H. Lee Moffitt Cancer Center

Tampa, Florida - Recruiting

Dana-Farber Cancer Institute

Boston, Massachusetts - Recruiting

Massachusetts General Hospital

Boston, Massachusetts - Recruiting

Fox Chase Cancer Center

Philadelphia, Pennsylvania - Recruiting

UT MD Anderson Cancer Center

Houston, Texas - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.